Gallbladder Myeloid Sarcoma Associated With NPM1 Mutated Acute Myeloid Leukemia
eJHaem, Volume 6, Issue 4, August 2025.
Francesco Grimaldi+5 more
wiley +1 more source
IgG4‐Related Disease Mimicking Metastatic Malignancy: Polyserositis and Abdominal Lymphadenopathy
ABSTRACT In patients presenting with multiple space‐occupying lesions, preserved general condition, and normal or mildly elevated tumor markers, IgG4‐related disease (IgG4‐RD) should be considered in the differential diagnosis. We report an extremely unusual case of IgG4‐RD mimicking metastatic malignancy, with polyserositis and widespread abdominal ...
Meisi Huo+3 more
wiley +1 more source
Effect of simple vs. extended cholecystectomy on prognosis of T1b gallbladder cancer: a systematic review and meta-analysis. [PDF]
Gu H, Zhang G, Ma H, Yu Z.
europepmc +1 more source
Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas [PDF]
Zhihao Zhao+4 more
openalex +1 more source
Aggressive Myeloid Sarcoma Mimicking Burkitt's Lymphoma
eJHaem, Volume 6, Issue 4, August 2025.
Eman Hassan+4 more
wiley +1 more source
ABSTRACT Background and Aims Obesity is a multifaceted health issue that significantly elevates the risk of various chronic diseases and can lead to a reduction in life expectancy by 5–20 years. This study aimed to estimate both the direct and indirect costs associated with obesity among the population served by Iran University of Medical Sciences in ...
Mahmoud Zamandi+3 more
wiley +1 more source
Case report and literature review of gallbladder paraganglioma in patient with inflammatory bowel disease. [PDF]
Dominkovic M, Allan L, Pleass H.
europepmc +1 more source
Kojima and colleagues evaluated the diagnostic and therapeutic performance of advanced endoscopic ultrasonography in pancreaticobiliary diseases using novel scopes and imaging techniques such as detective flow imaging and shear wave elastography. These innovations achieved high technical and clinical success rates, enhancing safety and diagnostic ...
Hiroyuki Kojima+9 more
wiley +1 more source
Clinicopathological characteristics of 30 cases of pyloric gland adenoma: a single center case series. [PDF]
Hou J, Meng F, Yue B, Li P, Dong N.
europepmc +1 more source
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors
CVL218, a PARP1/2 inhibitor, was generally well tolerated and safe in solid tumors. It showed potential antitumor activity in patients treated with the recommended dose (700 mg BID). ABSTRACT CVL218, a novel poly ADP‐ribose polymerase (PARP1/2) inhibitor, has strong PARP1/2 selective inhibitory activity and high oral bioavailability. We aimed to assess
Zihong Chen+12 more
wiley +1 more source